市場調査レポート

商品コード

1277623

男性不妊症の世界市場：予測（2023年～2032年）

Global Male Infertility Market Forecast 2023-2032

出版日: 2023年05月20日 | 発行: Inkwood Research

| ページ情報: 英文 238 Pages | 納期: 2～3営業日

価格

Unprintable PDF (Single User License)

USD 2,900 455,706円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。PDFの印刷もできません。

PDF (Corporate License)

USD 4,500 707,130円

レポートPDFを同一企業内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の男性不妊症の市場規模は、2023年～2032年までの予測期間中に4.53%のCAGRで拡大すると予測されています。不妊症の急増、生殖補助医療技術の採用、技術的進歩が世界市場の成長を後押ししています。

当レポートでは、世界の男性不妊症市場について調査し、市場の概要とともに、検査タイプ別、治療別、地域別の動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

主要な戦略的展開
企業プロファイル
- ADVACARE PHARMA USA
- ANDROLOGY SOLUTIONS
- AYTU BIOPHARMA
- BAYER GROUP
- CAERUS BIOTECH
- CINNAGEN CO
- EMD SERONO INC (MERCK SERONO)
- ENDO INTERNATIONAL PLC
- HALOTECH DNA
- LABORATORY CORPORATION OF AMERICA HOLDINGS
- SANOFI
- SCSA DIAGNOSTICS
- THERAMEX
- VITROLIFE
- ZYDUS LIFESCIENCES LTD (CADILA HEALTHCARE LTD)

図表

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - MALE INFERTILITY
TABLE 2: GLOBAL MALE INFERTILITY MARKET, BY TEST TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: GLOBAL MALE INFERTILITY MARKET, BY TEST TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 4: GLOBAL DNA FRAGMENTATION TECHNIQUE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: GLOBAL DNA FRAGMENTATION TECHNIQUE MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: GLOBAL OXIDATIVE STRESS ANALYSIS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: GLOBAL OXIDATIVE STRESS ANALYSIS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: GLOBAL MICROSCOPIC EXAMINATION MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: GLOBAL MICROSCOPIC EXAMINATION MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 10: GLOBAL SPERM AGGLUTINATION MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: GLOBAL SPERM AGGLUTINATION MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 12: GLOBAL COMPUTER-ASSISTED SEMEN ANALYSIS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 13: GLOBAL COMPUTER-ASSISTED SEMEN ANALYSIS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 14: GLOBAL SPERM PENETRATION ASSAY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 15: GLOBAL SPERM PENETRATION ASSAY MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 16: GLOBAL OTHER TEST TYPES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 17: GLOBAL OTHER TEST TYPES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 18: GLOBAL MALE INFERTILITY MARKET, BY TREATMENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 19: GLOBAL TREATMENT MARKET, BY TREATMENT, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 20: GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY AND SURGERY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 21: GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY AND SURGERY MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 22: GLOBAL MEDICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 23: GLOBAL MEDICATIONS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 24: GLOBAL MALE INFERTILITY MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 25: GLOBAL MALE INFERTILITY MARKET, BY GEOGRAPHY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 26: NORTH AMERICA MALE INFERTILITY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 27: NORTH AMERICA MALE INFERTILITY MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 28: KEY PLAYERS OPERATING IN NORTH AMERICA MALE INFERTILITY MARKET
TABLE 29: EUROPE MALE INFERTILITY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 30: EUROPE MALE INFERTILITY MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 31: KEY PLAYERS OPERATING IN EUROPE MALE INFERTILITY MARKET
TABLE 32: ASIA-PACIFIC MALE INFERTILITY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 33: ASIA-PACIFIC MALE INFERTILITY MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 34: KEY PLAYERS OPERATING IN ASIA-PACIFIC MALE INFERTILITY MARKET
TABLE 35: REST OF WORLD MALE INFERTILITY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 36: REST OF WORLD MALE INFERTILITY MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 37: KEY PLAYERS OPERATING IN REST OF WORLD MALE INFERTILITY MARKET
TABLE 38: LIST OF MERGERS & ACQUISITIONS
TABLE 39: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 40: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 41: LIST OF BUSINESS EXPANSIONS

LIST OF FIGURES

FIGURE 1: PORTER'S FIVE FORCES ANALYSIS
FIGURE 2: GROWTH PROSPECT MAPPING FOR UNITED STATES
FIGURE 3: GROWTH PROSPECT MAPPING FOR SPAIN
FIGURE 4: GROWTH PROSPECT MAPPING FOR SOUTH KOREA
FIGURE 5: GROWTH PROSPECT MAPPING FOR MIDDLE EAST & AFRICA
FIGURE 6: MARKET MATURITY ANALYSIS
FIGURE 7: MARKET CONCENTRATION ANALYSIS
FIGURE 8: GLOBAL MALE INFERTILITY MARKET, GROWTH POTENTIAL, BY TEST TYPE, IN 2022
FIGURE 9: GLOBAL MALE INFERTILITY MARKET, BY DNA FRAGMENTATION TECHNIQUE, 2023-2032 (IN $ MILLION)
FIGURE 10: GLOBAL MALE INFERTILITY MARKET, BY DNA FRAGMENTATION TECHNIQUE, 2023-2032 (IN $ MILLION)
FIGURE 11: GLOBAL MALE INFERTILITY MARKET, BY OXIDATIVE STRESS ANALYSIS, 2023-2032 (IN $ MILLION)
FIGURE 12: GLOBAL MALE INFERTILITY MARKET, BY MICROSCOPIC EXAMINATION, 2023-2032 (IN $ MILLION)
FIGURE 13: GLOBAL MALE INFERTILITY MARKET, BY SPERM AGGLUTINATION, 2023-2032 (IN $ MILLION)
FIGURE 14: GLOBAL MALE INFERTILITY MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS, 2023-2032 (IN $ MILLION)
FIGURE 15: GLOBAL MALE INFERTILITY MARKET, BY SPERM PENETRATION ASSAY, 2023-2032 (IN $ MILLION)
FIGURE 16: GLOBAL MALE INFERTILITY MARKET, BY OTHER TEST TYPES, 2023-2032 (IN $ MILLION)
FIGURE 17: GLOBAL TREATMENT MARKET, GROWTH POTENTIAL, BY TREATMENT, IN 2022
FIGURE 18: GLOBAL MALE INFERTILITY MARKET, BY ASSISTED REPRODUCTIVE TECHNOLOGY AND SURGERY, 2023-2032 (IN $ MILLION)
FIGURE 19: GLOBAL MALE INFERTILITY MARKET, BY MEDICATIONS, 2023-2032 (IN $ MILLION)
FIGURE 20: NORTH AMERICA MALE INFERTILITY MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
FIGURE 21: UNITED STATES MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 22: CANADA MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 23: EUROPE MALE INFERTILITY MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
FIGURE 24: UNITED KINGDOM MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 25: GERMANY MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 26: FRANCE MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 27: ITALY MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 28: SPAIN MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 29: BELGIUM MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 30: POLAND MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 31: REST OF EUROPE MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 32: ASIA-PACIFIC MALE INFERTILITY MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN%)
FIGURE 33: CHINA MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 34: JAPAN MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 35: INDIA MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 36: SOUTH KOREA MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 37: INDONESIA MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 38: THAILAND MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 39: VIETNAM MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 40: AUSTRALIA & NEW ZEALAND MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 41: REST OF ASIA-PACIFIC MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 42: REST OF WORLD MALE INFERTILITY MARKET, REGIONAL OUTLOOK, 2022 & 2032 (IN %)
FIGURE 43: LATIN AMERICA MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 44: MIDDLE EAST & AFRICA MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)

Product Code: 51594

KEY FINDINGS

The global male infertility market is predicted to record a 4.53% CAGR during the forecast period from 2023 to 2032. Surging incidences of infertility, adoption of assisted reproductive technologies, and technological advancements boost the market growth globally.

MARKET INSIGHTS

Several significant factors drive the growth of the global male infertility market, including issues with sperm production or delivery, such as low sperm count, abnormal sperm function, or blockages, commonly cause male infertility. Additionally, illnesses, chronic health problems, injuries, lifestyle choices, and other factors contribute to male infertility.

The surging incidence of infertility and the adoption of assisted reproductive technologies (ART) are crucial in addressing male infertility challenges. Assisted reproductive technologies provide a viable solution for men facing infertility issues, offering higher success rates compared to medications. The widespread adoption of these technologies has increased pregnancy possibilities for infertile couples worldwide, contributing to the growth of the male infertility market.

REGIONAL INSIGHTS

The global male infertility market evaluation comprises a study of Asia-Pacific, North America, Europe, and Rest of World. Europe is estimated to dominate in terms of market share owing to the increased adoption of affordable therapies and devices, assisted reproductive technologies, and reimbursement coverage.

COMPETITIVE INSIGHTS

The global male infertility market is characterized by intense competition due to the presence of numerous companies. These companies strive to develop innovative products for infertility treatment, and regional players compete with established brands. Market players focus on conducting clinical trials, developing new products, and launching novel solutions to gain a competitive edge.

Leading market players include: CinnaGen Co, Endo International PLC, Caerus Biotech, EMD Serono Inc (Merck Serono), etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
- 2.5.1. PRODUCT DEVELOPMENTS AND LAUNCHES BY MARKET PLAYERS PROMOTE MARKET GROWTH
- 2.5.2. PREVALENCE OF DIABETES AND CANCER

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. SURGING INFERTILITY INCIDENCES
- 3.1.2. ASSISTED REPRODUCTIVE TECHNOLOGY ADOPTION
- 3.1.3. TECHNOLOGICAL ADVANCEMENTS
3.2. KEY RESTRAINTS
- 3.2.1. HIGH TREATMENT COSTS

4. KEY ANALYTICS

4.1. KEY MARKET TRENDS
4.2. PORTER'S FIVE FORCES ANALYSIS
- 4.2.1. BUYERS POWER
- 4.2.2. SUPPLIERS POWER
- 4.2.3. SUBSTITUTION
- 4.2.4. NEW ENTRANTS
- 4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
4.4. MARKET MATURITY ANALYSIS
4.5. MARKET CONCENTRATION ANALYSIS

5. MARKET BY TEST TYPE

5.1. DNA FRAGMENTATION TECHNIQUE
5.2. OXIDATIVE STRESS ANALYSIS
5.3. MICROSCOPIC EXAMINATION
5.4. SPERM AGGLUTINATION
5.5. COMPUTER-ASSISTED SEMEN ANALYSIS
5.6. SPERM PENETRATION ASSAY
5.7. OTHER TEST TYPES

6. MARKET BY TREATMENT

6.1. ASSISTED REPRODUCTIVE TECHNOLOGY AND SURGERY
6.2. MEDICATIONS

7. GEOGRAPHICAL ANALYSIS

7.1. NORTH AMERICA
- 7.1.1. MARKET SIZE & ESTIMATES
- 7.1.2. NORTH AMERICA MALE INFERTILITY MARKET DRIVERS
- 7.1.3. NORTH AMERICA MALE INFERTILITY MARKET CHALLENGES
- 7.1.4. KEY PLAYERS IN NORTH AMERICA MALE INFERTILITY MARKET
- 7.1.5. COUNTRY ANALYSIS
  - 7.1.5.1. UNITED STATES
  - 7.1.5.1.1. UNITED STATES MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.1.5.2. CANADA
  - 7.1.5.2.1. CANADA MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
7.2. EUROPE
- 7.2.1. MARKET SIZE & ESTIMATES
- 7.2.2. EUROPE MALE INFERTILITY MARKET DRIVERS
- 7.2.3. EUROPE MALE INFERTILITY MARKET CHALLENGES
- 7.2.4. KEY PLAYERS IN EUROPE MALE INFERTILITY MARKET
- 7.2.5. COUNTRY ANALYSIS
  - 7.2.5.1. UNITED KINGDOM
  - 7.2.5.1.1. UNITED KINGDOM MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.2.5.2. GERMANY
  - 7.2.5.2.1. GERMANY MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.2.5.3. FRANCE
  - 7.2.5.3.1. FRANCE MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.2.5.4. ITALY
  - 7.2.5.4.1. ITALY MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.2.5.5. SPAIN
  - 7.2.5.5.1. SPAIN MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.2.5.6. BELGIUM
  - 7.2.5.6.1. BELGIUM MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.2.5.7. POLAND
  - 7.2.5.7.1. POLAND MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.2.5.8. REST OF EUROPE
  - 7.2.5.8.1. REST OF EUROPE MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
7.3. ASIA-PACIFIC
- 7.3.1. MARKET SIZE & ESTIMATES
- 7.3.2. ASIA-PACIFIC MALE INFERTILITY MARKET DRIVERS
- 7.3.3. ASIA-PACIFIC MALE INFERTILITY MARKET CHALLENGES
- 7.3.4. KEY PLAYERS IN ASIA-PACIFIC MALE INFERTILITY MARKET
- 7.3.5. COUNTRY ANALYSIS
  - 7.3.5.1. CHINA
  - 7.3.5.1.1. CHINA MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.3.5.2. JAPAN
  - 7.3.5.2.1. JAPAN MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.3.5.3. INDIA
  - 7.3.5.3.1. INDIA MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.3.5.4. SOUTH KOREA
  - 7.3.5.4.1. SOUTH KOREA MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.3.5.5. INDONESIA
  - 7.3.5.5.1. INDONESIA MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.3.5.6. THAILAND
  - 7.3.5.6.1. THAILAND MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.3.5.7. VIETNAM
  - 7.3.5.7.1. VIETNAM MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.3.5.8. AUSTRALIA & NEW ZEALAND
  - 7.3.5.8.1. AUSTRALIA & NEW ZEALAND MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.3.5.9. REST OF ASIA-PACIFIC
  - 7.3.5.9.1. REST OF ASIA-PACIFIC MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
7.4. REST OF WORLD
- 7.4.1. MARKET SIZE & ESTIMATES
- 7.4.2. REST OF WORLD MALE INFERTILITY MARKET DRIVERS
- 7.4.3. REST OF WORLD MALE INFERTILITY MARKET CHALLENGES
- 7.4.4. KEY PLAYERS IN REST OF WORLD MALE INFERTILITY MARKET
- 7.4.5. REGIONAL ANALYSIS
  - 7.4.5.1. LATIN AMERICA
  - 7.4.5.1.1. LATIN AMERICA MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.4.5.2. MIDDLE EAST & AFRICA
  - 7.4.5.2.1. MIDDLE EAST & AFRICA MALE INFERTILITY MARKET SIZE & OPPORTUNITIES

8. COMPETITIVE LANDSCAPE

8.1. KEY STRATEGIC DEVELOPMENTS
- 8.1.1. MERGERS & ACQUISITIONS
- 8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 8.1.3. PARTNERSHIPS & AGREEMENTS
- 8.1.4. BUSINESS EXPANSIONS
8.2. COMPANY PROFILES
- 8.2.1. ADVACARE PHARMA USA
  - 8.2.1.1. COMPANY OVERVIEW
  - 8.2.1.2. PRODUCTS / SERVICES LIST
- 8.2.2. ANDROLOGY SOLUTIONS
  - 8.2.2.1. COMPANY OVERVIEW
  - 8.2.2.2. PRODUCTS / SERVICES LIST
- 8.2.3. AYTU BIOPHARMA
  - 8.2.3.1. COMPANY OVERVIEW
  - 8.2.3.2. PRODUCTS / SERVICES LIST
  - 8.2.3.3. STRENGTHS & CHALLENGES
- 8.2.4. BAYER GROUP
  - 8.2.4.1. COMPANY OVERVIEW
  - 8.2.4.2. PRODUCTS / SERVICES LIST
  - 8.2.4.3. STRENGTHS & CHALLENGES
- 8.2.5. CAERUS BIOTECH
  - 8.2.5.1. COMPANY OVERVIEW
  - 8.2.5.2. PRODUCTS / SERVICES LIST
- 8.2.6. CINNAGEN CO
  - 8.2.6.1. COMPANY OVERVIEW
  - 8.2.6.2. PRODUCTS / SERVICES LIST
  - 8.2.6.3. STRENGTHS & CHALLENGES
- 8.2.7. EMD SERONO INC (MERCK SERONO)
  - 8.2.7.1. COMPANY OVERVIEW
  - 8.2.7.2. PRODUCTS / SERVICES LIST
  - 8.2.7.3. STRENGTHS & CHALLENGES
- 8.2.8. ENDO INTERNATIONAL PLC
  - 8.2.8.1. COMPANY OVERVIEW
  - 8.2.8.2. PRODUCTS / SERVICES LIST
  - 8.2.8.3. STRENGTHS & CHALLENGES
- 8.2.9. HALOTECH DNA
  - 8.2.9.1. COMPANY OVERVIEW
  - 8.2.9.2. PRODUCTS / SERVICES LIST
- 8.2.10. LABORATORY CORPORATION OF AMERICA HOLDINGS
  - 8.2.10.1. COMPANY OVERVIEW
  - 8.2.10.2. PRODUCTS / SERVICES LIST
  - 8.2.10.3. STRENGTHS & CHALLENGES
- 8.2.11. SANOFI
  - 8.2.11.1. COMPANY OVERVIEW
  - 8.2.11.2. PRODUCTS / SERVICES LIST
  - 8.2.11.3. STRENGTHS & CHALLENGES
- 8.2.12. SCSA DIAGNOSTICS
  - 8.2.12.1. COMPANY OVERVIEW
  - 8.2.12.2. PRODUCTS / SERVICES LIST
- 8.2.13. THERAMEX
  - 8.2.13.1. COMPANY OVERVIEW
  - 8.2.13.2. PRODUCTS / SERVICES LIST
- 8.2.14. VITROLIFE
  - 8.2.14.1. COMPANY OVERVIEW
  - 8.2.14.2. PRODUCTS / SERVICES LIST
  - 8.2.14.3. STRENGTHS & CHALLENGES
- 8.2.15. ZYDUS LIFESCIENCES LTD (CADILA HEALTHCARE LTD)
  - 8.2.15.1. COMPANY OVERVIEW
  - 8.2.15.2. PRODUCTS / SERVICES LIST
  - 8.2.15.3. STRENGTHS & CHALLENGES

男性不妊症の世界市場：予測（2023年～2032年）

Global Male Infertility Market Forecast 2023-2032

目次

第1章調査範囲と調査手法

第2章エグゼクティブサマリー

第3章市場力学

第4章主要な分析

第5章検査タイプ別市場

第6章治療別市場

第7章地域別分析

第8章競合情勢

LIST OF TABLES

LIST OF FIGURES

KEY FINDINGS

MARKET INSIGHTS

REGIONAL INSIGHTS

COMPETITIVE INSIGHTS

Our report offerings include:

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

2. EXECUTIVE SUMMARY

3. MARKET DYNAMICS

4. KEY ANALYTICS

5. MARKET BY TEST TYPE

6. MARKET BY TREATMENT

7. GEOGRAPHICAL ANALYSIS

8. COMPETITIVE LANDSCAPE

男性不妊症の世界市場：予測（2023年～2032年）

Global Male Infertility Market Forecast 2023-2032

目次

第1章 調査範囲と調査手法

第2章 エグゼクティブサマリー

第3章 市場力学

第4章 主要な分析

第5章 検査タイプ別市場

第6章 治療別市場

第7章 地域別分析

第8章 競合情勢

LIST OF TABLES

LIST OF FIGURES

KEY FINDINGS

MARKET INSIGHTS

REGIONAL INSIGHTS

COMPETITIVE INSIGHTS

Our report offerings include:

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

2. EXECUTIVE SUMMARY

3. MARKET DYNAMICS

4. KEY ANALYTICS

5. MARKET BY TEST TYPE

6. MARKET BY TREATMENT

7. GEOGRAPHICAL ANALYSIS

8. COMPETITIVE LANDSCAPE

第1章調査範囲と調査手法

第2章エグゼクティブサマリー

第3章市場力学

第4章主要な分析

第5章検査タイプ別市場

第6章治療別市場

第7章地域別分析

第8章競合情勢